Neurodon is a Development Stage Company with Patent-pending Drug Candidates for Major Diseases
  • Assets in Neurodegeneration & Metabolic Disease
  • Several programs in lead op/pre-IND stage
  • Novel platform technology – ER Stress
  • Little/no competition
  • Clinically Validated for multiple major diseases
  • Neurodon is the leader in targeting ER stress (patents, publications, traction, etc.)